Welcome to our dedicated page for Integral Acquisition SEC filings (Ticker: INTE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Integral Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Integral Acquisition's regulatory disclosures and financial reporting.
Integral Acquisition Corporation 1 extended its deadline to complete a business combination to November 5, 2026 after stockholders approved a Fourth Extension Amendment.
Holders voted 3,064,876 “for” and 4 “against.” In connection with the vote, stockholders redeemed 171,949 Public Shares at approximately $11.68 per share, for about $2.0 million, leaving 190,721 Public Shares outstanding.
To support the extension, the Sponsor provided a no‑interest promissory note of up to $114,432.60. The Company will deposit $9,536.05 into the trust each month, beginning November 6, 2025 and on the 5th of each following month, until November 5, 2026. The note is repayable in full upon the closing of a business combination or upon liquidation. The amendment to the charter became effective upon filing on November 3, 2025.
Integral Acquisition Corporation 1 called a special meeting on October 31, 2025 to vote on two items: a Fourth Extension to push the SPAC deadline to November 5, 2026 and, if needed, an adjournment to solicit more votes.
Public stockholders may redeem at a cash price equal to funds in the trust divided by public shares. As of October 10, 2025, the trust held about $4,226,391, or roughly $11.65 per Public Share, before taxes. If the extension is approved and implemented, the Sponsor agreed to loan $0.05 per non‑redeemed Public Share each month through November 5, 2026, deposited into the trust; these loans bear no interest and are repayable at business combination closing.
The extension requires an affirmative vote of at least 65% of outstanding common stock. The Sponsor, directors and officers collectively hold about 87.3% of voting power and plan to vote for both proposals. If the extension is not completed and no deal closes by the current deadline, the company will redeem all Public Shares and liquidate; warrants would expire worthless.